Adrien Krug

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Replacement Therapy

Chronic Myeloid Leukemia

Dendritic Cells

Immune Response

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Fabien Muselli, Lucas Mourgues, Nathalie Rochet, Marielle Nebout, Agnès Guerci, Els Verhoeyen, Adrien Krug, Laurence Legros, Jean-François Peyron, Didier Mary
Repurposing the Bis-Biguanide Alexidine in Combination with Tyrosine Kinase Inhibitors to Eliminate Leukemic Stem/Progenitor Cells in Chronic Myeloid Leukemia. Cancers 15 (3) (2023)
Fabien Muselli, Lucas Mourgues, Nathalie Rochet, Marielle Nebout, Agnès Guerci, Els Verhoeyen, Adrien Krug, Laurence Legros, Jean-François Peyron, Didier Mary
Repurposing the Bis-Biguanide Alexidine in Combination with Tyrosine Kinase Inhibitors to Eliminate Leukemic Stem/Progenitor Cells in Chronic Myeloid Leukemia. Cancers 15 (3) (2023)
Adrien Krug, Gamze Tari, Aymen Saidane, Philippe Gaulard, Jean-Ehrland Ricci, François Lemonnier, Els Verhoeyen
Novel T Follicular Helper-like T-Cell Lymphoma Therapies: From Preclinical Evaluation to Clinical Reality. Cancers 14 (10) (2022)
Adrien Krug, Adriana Martinez-Turtos, Els Verhoeyen
Importance of T, NK, CAR T and CAR NK Cell Metabolic Fitness for Effective Anti-Cancer Therapy: A Continuous Learning Process Allowing the Optimization of T, NK and CAR-Based Anti-Cancer Therapies. Cancers 14 (1) (2021)